These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 26187018)

  • 1. Intra- and Interinstitutional Evaluation of an Etest for Vancomycin Minimum Inhibitory Concentration Measurement in Staphylococcus aureus Blood Isolates.
    Falcón R; Madrid S; Tormo N; Casañ C; Albert E; Gimeno C; Navarro D
    Clin Infect Dis; 2015 Nov; 61(9):1490-2. PubMed ID: 26187018
    [No Abstract]   [Full Text] [Related]  

  • 2. Vancomycin minimum inhibitory concentration in methicillin-susceptible Staphylococcus aureus and mortality: more than handwaving?
    Kaasch AJ; Jung N; Fätkenheuer G; Seifert H
    Clin Infect Dis; 2015 Feb; 60(4):668. PubMed ID: 25371487
    [No Abstract]   [Full Text] [Related]  

  • 3. Reply to Kaasch et al.
    Cervera C; Garcia de la Maria C; Pericas JM; Moreno A; Miro JM
    Clin Infect Dis; 2015 Feb; 60(4):669-70. PubMed ID: 25371491
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of vancomycin minimal inhibitory concentration on the outcome of methicillin-susceptible Staphylococcus aureus endocarditis.
    Cervera C; Castañeda X; de la Maria CG; del Rio A; Moreno A; Soy D; Pericas JM; Falces C; Armero Y; Almela M; Ninot S; Pare JC; Mestres CA; Gatell JM; Marco F; Miro JM;
    Clin Infect Dis; 2014 Jun; 58(12):1668-75. PubMed ID: 24647021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative activity of cloxacillin and vancomycin against methicillin-susceptible Staphylococcus aureus experimental endocarditis.
    Fernández Guerrero ML; de Górgolas M
    J Antimicrob Chemother; 2006 Nov; 58(5):1066-9. PubMed ID: 16931540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of vancomycin minimum inhibitory concentration on the outcome of methicillin-susceptible Staphylococcus aureus left-sided infective endocarditis treated with antistaphylococcal β-lactam antibiotics: a prospective cohort study by the International Collaboration on Endocarditis.
    Pericàs JM; Messina JA; Garcia-de-la-Mària C; Park L; Sharma-Kuinkel BK; Marco F; Wray D; Kanafani ZA; Carugati M; Durante-Mangoni E; Tattevin P; Chu VH; Moreno A; Fowler VG; Miró JM;
    Clin Microbiol Infect; 2017 Aug; 23(8):544-549. PubMed ID: 28159672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative efficacy of amoxicillin-clavulanate, cloxacillin, and vancomycin against methicillin-sensitive and methicillin-resistant Staphylococcus aureus endocarditis in rats.
    Cantoni L; Wenger A; Glauser MP; Bille J
    J Infect Dis; 1989 May; 159(5):989-93. PubMed ID: 2708846
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cloxacillin-susceptible Staphylococcus aureus with high MIC to glycopeptides. Ever we use cloxacillin?].
    Morales-Cartagena A; Lalueza A; San Juan R; Aguado JM
    Rev Esp Quimioter; 2015 Sep; 28 Suppl 1():25-9. PubMed ID: 26365730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocarditis caused by Staphylococcus aureus with reduced susceptibility to vancomycin.
    Woods CW; Cheng AC; Fowler VG; Moorefield M; Frederick J; Sakoulas G; Meka VG; Tenover FC; Zwadyk P; Wilson KH
    Clin Infect Dis; 2004 Apr; 38(8):1188-91. PubMed ID: 15095227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of ciprofloxacin in treatment and prophylaxis of experimental Staphylococcus aureus endocarditis caused by a cloxacillin-tolerant strain and its non-tolerant variant.
    Voorn GP; Thompson J; Goessens WH; Schmal-Bauer WC; Broeders PH; Michel MF
    J Antimicrob Chemother; 1994 Apr; 33(4):785-94. PubMed ID: 8056697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vancomycin failure in staphylococcal endocarditis.
    Jackson MA; Hicks RA
    Pediatr Infect Dis J; 1987 Aug; 6(8):750-2. PubMed ID: 3499592
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of vancomycin in the treatment of severe Staphylococcus aureus infection. Description of 3 cases].
    Campelli A; Mantero E; Fabbri A; Nahum M; Ferraris R; Di Noto C
    Minerva Med; 1984 Feb; 75(8):385-90. PubMed ID: 6709217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of vancomycin in the treatment paradigm.
    Stevens DL
    Clin Infect Dis; 2006 Jan; 42 Suppl 1():S51-7. PubMed ID: 16323121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of cloxacillin in treatment of a patient with borderline oxacillin-resistant Staphylococcus aureus endocarditis.
    Skinner S; Murray M; Walus T; Karlowsky JA
    J Clin Microbiol; 2009 Mar; 47(3):859-61. PubMed ID: 19116360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy of a vancomycin brain heart infusion screening plate for the screening of Staphylococcus aureus isolates with increased vancomycin minimum inhibitory concentrations.
    Navarini A; Martino MD; Sasagawa SM; Massaia IF; Mimica MJ
    New Microbiol; 2015 Jul; 38(3):423-6. PubMed ID: 26147148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The first pediatric case of Staphylococcus aureus with heterogenous resistant to vancomycin endocarditis in Thailand.
    Phongsamart W; Srifeungfung S; Tiensasitorn C; Vanprapar N; Chearskul S; Chokephaibulkit K
    J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S264-8. PubMed ID: 16856450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effectiveness of various antibiotics in the treatment of methicillin-susceptible Staphylococcus aureus experimental infective endocarditis.
    Apellaniz G; Valdés M; Perez R; Martin F; Soria F; Garcia A; Gòmez J; Vicente T
    J Chemother; 1991 Apr; 3(2):91-7. PubMed ID: 1875239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Teicoplanin versus cloxacillin, cloxacillin-gentamycin and vancomycin in the treatment of experimental endocarditis caused by methicillin-sensitive Staphylococcus aureus].
    Apellaniz G; Valdés M; Pérez R; Martín-Luengo F; García A; Soria F; Gómez J
    Enferm Infecc Microbiol Clin; 1991 Apr; 9(4):208-10. PubMed ID: 1830757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cloxacilin and vancomycin bacterial action against oxalicin-susceptible Staphylococcus aureus].
    Mella S; Sepúlveda M; Bello H; Dominguez M; González G; Zemelman R
    Rev Med Chil; 2001 Feb; 129(2):224-6. PubMed ID: 11351477
    [No Abstract]   [Full Text] [Related]  

  • 20. Paradoxical relationship between the clinical outcome of Staphylococcus aureus bacteremia and the minimum inhibitory concentration of vancomycin.
    Price J; Atkinson S; Llewelyn M; Paul J
    Clin Infect Dis; 2009 Apr; 48(7):997-8. PubMed ID: 19260820
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.